First Horizon Advisors, Inc. Galapagos Nv Transaction History

First Horizon Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$52.17 - $70.2 $469 - $631	-9 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$68.86 - $83.34 $826 - $1,000	-12 Reduced 57.14%	9 $0
Q1 2021 May 11, 2021	BUY	$76.15 - $111.94 $1,523 - $2,238	20 Added 2000.0%	21 $1,000
Q4 2020 Feb 11, 2021	BUY	$96.85 - $148.25 $96 - $148	1 New	1 $0
Q3 2020 Nov 12, 2020	SELL	$122.47 - $213.56 $9,062 - $15,803	-74 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$143.0 - $274.03 $10,439 - $20,004	73 Added 7300.0%	74 $14,000
Q4 2019 Jan 07, 2020	BUY	$146.12 - $215.82 $146 - $215	1 New	1 $0

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.56B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.